• Hirom@beehaw.org
    link
    fedilink
    arrow-up
    2
    ·
    edit-2
    1 year ago

    I guess it would be more difficult to get approval than the average treatment if it’s the first of its kind.

    Also I’m not an expert in the field, and there are probably many factors that makes speculation difficult, such as funding, and does-it-work-in-humans, and funding.